September 2013 Oncology
Oral antineoplastics have advantages, but patient adherence is a concern.
Gilotrif (afatinib) is FDA approved for treating certain non-small cell lung cancers.
Why are computerized drug-drug interaction alerts usually ignored?
Pharmacists are in a pivotal position to help patients select and properly use at-home test and monitor kits.
The nutritional supplements glucosamine and chondroitin have demonstrated some potential for reducing pain associated with osteoarthritis
Federal rules are very specific.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
2
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
3
Fentanyl-Responsive Microneedle Patch Automatically Releases Naloxone in Preclinical Study
4
Delegating to Technicians: The Key to Pharmacists Practicing at Top of License
5